Views and experience of non-hospitalised individuals with Long COVID of using pacing interventions: a mixed methods study

Author:

McMullan Christel1,Haroon Shamil2,Turner Grace3,Aiyegbusi Olalekan1,Hughes Sarah1,Flanagan Sarah2,Subramanian Anuradhaa4,Nirantharakumar Krish2,Davies Elin5,Frost Chris5,Jackson Louise2,Guan Naijie2,Alder Yvonne1,Chong Amy1,Buckland Lewis1,Jeyes Felicity1,Stanton David1,Calvert Melanie1

Affiliation:

1. Centre for Patient Reported Outcomes Research, University of Birmingham

2. Institute of Applied Health Research, University of Birmingham

3. School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham

4. AstraZeneca (United Kingdom)

5. Aparito Ltd

Abstract

Abstract

Background Long COVID is highly prevalent and debilitating, with key symptoms including fatigue, breathlessness, and brain fog. Pacing is an approach to energy conservation used to help people with chronic conditions like ME/CFS manage the impact of their condition, and could be a useful strategy for people with Long COVID. The aim of this study was to explore the views and experiences of non-hospitalised adults with Long COVID of pacing as an intervention. Methods This mixed methods study is part of the Therapies for Long COVID (TLC) Feasibility trial. A feasibility questionnaire was developed for participants. In addition, a sub-sample of participants were interviewed at the end of the study. Results 28 participants completed the feasibility questionnaire and 19 participants took part in a qualitative interview. Participants found that pacing helped improve motivation and activity planning. Concerns included challenges due to time constraints, complexity of the intervention, and limited instructions. Conclusion Pacing for Long COVID may offer potential benefits and is feasible but further research is required to demonstrate its benefits. Overall, research on pacing in the context of Long COVID has the potential to enhance our understanding of symptom management and rehabilitation strategies for this emerging population.

Publisher

Research Square Platform LLC

Reference32 articles.

1. WHO. Post COVID-19 condition (Long COVID). 2022; Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation.

2. Statement on the fifteenth meeting of the International Health Regulations (2005) emergency committee regarding the coronavirus disease (COVID-19) pandemic. 2023 11/04/2024]

3. Available from: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic?adgroupsurvey=%7Badgroupsurvey%7D&gclid=EAIaIQobChMI4Ojtsdbe_gIVjQRyCh07igt4EAAYASACEgJ9pfD_BwE&fbclid=IwAR2M8EAyiSrAodhK9p-X582nHkP2AigpSX8pYIsLsPwqYh4SG26RGokGe7E.

4. Long COVID: major findings, mechanisms and recommendations;Davis HE;Nat Rev Microbiol,2023

5. ONS, Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3